- Home
- About mondoBIOTECH
- Investors
- Corporate Fact Sheet
- Company Presentation
- All Reports
- Corporate Governance
- Share Information
- Financial Calendar
- Shareholders’ Meeting
- Investor Relation Contact
- Media Releases
- Business Partners
- Pipeline
- Community
- Careers
- Contact Us
Search
| Investors - Media Releases | ||
| Stay Informed | ||
|
2009
| ||
| December 21, 2009 |
| Mondobiotech Holding AG (SIX: RARE) announced amendments of its articles of incorporation |
| STANS, Switzerland – December 21, 2009 – Mondobiotech Holding AG announced Friday, December 18, 2009, the convocation of an extraordinary shareholders' meeting to be held January 15, 2010 to amend its articles of incorporation. The invitation (agenda and proposals of the board of directors) is available under http://www.mondobiotech.com/Investors/General_Meeting.cfm |
| December 18, 2009 |
| Mondobiotech Holding AG (SIX: RARE) intends to amend its articles of incorporation |
| STANS, Switzerland – December 18, 2009 – Mondobiotech Holding AG announces today the convocation of an extraordinary shareholders' meeting to be held January 15, 2010 to amend its articles of incorporation. The board of directors proposes to create statutory basis for the granting of option rights to existing and/or new shareholders in connection with future capital increases which shall be covered by the already existing conditional share capital. The planned amendment will allow the company to be flexible and opportunity oriented in designing its future capital market transactions. The board of directors further proposes certain changes to the articles of incorporation due to the entry into force of the new Intermediated Security Act on January 1, 2010. |
| December 02, 2009 |
| Evelyn Strauss appointed Director of Health Information Services |
| STANS, Switzerland – PALO ALTO, California – Mondobiotech Holding AG (SIX:RARE), the Swiss biotech firm that is finding therapies for rare diseases, announced today that Evelyn Strauss, Ph.D. has been appointed Director of Health Information Services. She will oversee Mondobiotech’s health-information program, which aims to advance the company’s mission of transforming treatment of rare diseases. |
| November 27, 2009 |
| Sandra Senti appointed Chief Information Officer |
| STANS, Switzerland – PALO ALTO, California, USA - Mondobiotech Holding AG (SIX:RARE), the Swiss biotech firm that is finding therapies for rare diseases, announced today that Sandra Senti has been appointed the company’s first Chief Information Officer. Ms. Senti will be responsible for the entire range of information technology infrastructure, administrative applications, and web realization of Mondobiotech. She will be based in the Palo Alto office, but will travel often to Switzerland. |
| November 18, 2009 |
| Mondobiotech Holding AG (SIX:RARE) expands in Silicon Valley |
| STANS, Switzerland - PALO ALTO – United States - November 18, 2009 – Mondobiotech (Mondobiotech Holding AG: SIX: RARE) today announces the growth in the United States for its Internet activities. The growth of Mondobiotech needs more and more profiles which can be found only in Silicon Valley. Palo Alto will be the social networking basis, the center of web-based operations on Mondobiotech’s pipeline of 300 medicinal product candidates and for the management of Mondobiotech’s Community. |
| October 19, 2009 |
| October 19, 2009 |
| Mondobiotech holding AG announced today its intention to soft sounding the financial markets referring to the terms of a share capital increase by way of a rights offering, intended to be completed presumably within the end of the year 2009. The company, pursuant to the strategy mentioned into its listing prospectus dated august 26, 2009, intends to use the proceeds to further increase its development pipeline. The terms of the transaction were not yet disclosed. |
| September 24, 2009 |
| Mondobiotech and Bachem agree long-term cooperation on the development of peptides to fight rare diseases |
| Stans and Bubendorf, Switzerland – September 24, 2009 Mondobiotech (Mondobiotech Holding AG: SIX: RARE) and Bachem (SIX: BANB) today announced the conclusion of a long-term cooperation. |
| September 17, 2009 |
| Mondobiotech Holding AG (SIX: RARE) announces pulmonary vasodilative properties of aerosolized B-type natriuretic peptide |
| STANS, Switzerland – September 17, 2009 – Beneficial pulmonary properties of aerosolized B-type natriuretic peptide |
| August 26, 2009 |
| A sincere word of thanks from Mondobiotech's founders |
| Mondobiotech Holding AG went public today on the SIX Swiss Exchange in Zürich under the ticker tape symbol RARE. We are deeply grateful to all the investors who have embraced Mondobiotech's philosophy, business model, and commitment to assist the community of patients suffering from rare and neglected diseases. Since this morning's listing, our stock's value has increased by 34.48 %. Today's launch represents little more than a beginning. But we believe that it augurs well for a future in which Mondobiotechs core mission will be fulfilled: improving the lives of millions of patients afflicted by rare and neglected diseases. |
| August 26, 2009 |
| Mondobiotech Holding AG goes public on 26th August 2009 at the SIX Swiss Exchange in Zürich under the SIX Symbol RARE |
| August 25, 2009 |
| Rare Diseases Day - Open Door |
| March 02, 2009 |
| President of the Swiss Cancer League Prof. Thomas Cerny Joins the Mondobiotech Board |
|
STANS, Switzerland – March 2, 2009 – Mondobiotech, the Swiss open source biotech company, today announced the appointment of Prof. Dr. med. Thomas Cerny, University of St. Gallen, Switzerland, to Mondobiotech’s Board. |
| March 02, 2009 |
| Internet Innovator from Silicon Valley Michael A. Keller Joins the Mondobiotech Board |
|
STANS, Switzerland – March 2, 2009 – Mondobiotech, the Swiss open source biotech company, announced today that Prof. Michael A. Keller, Stanford University, CA, entered into Mondobiotech’s Board |
| February 27, 2009 |
| Rare Disease Day |
| February 27, 2009 - Mondobiotech, together with the World, celebrates International Rare Disease Day 2009 |
| February 23, 2009 |
| Mondobiotech on Swiss TV SF1 Channel at ‘ECO’ Programme |
| January 28, 2009 |
| 23andMe and Mondobiotech Partner to Advance Research of Rare Diseases |
Davos, Switzerland – January 28th 2009 –23andMe, Inc., an industry leader in personal genetics, and Mondobiotech AG, a Swiss research company dedicated to the development of treatments for rare diseases, today announced at the World Economic Forum in Davos, Switzerland, that they are collaborating to advance research of rare diseases. The announcement marks the return of the companies to the World Economic Forum, where they both were recognized as Technology Pioneers in 2008. |
| January 27, 2009 |
| Fabio Cavalli, CEO of Mondobiotech, guest at TV Show 'Contesto' |
| The CEO of Mondobiotech, Fabio Cavalli, was a guest at the TV show 'Contesto', broadcasted by TSI1 on the 27 of January 2009 at 7:40PM. He engaged in a face-to-face discussion on the heated topic: "For or Against the World Economic Forum?" Il CEO Fabio Cavalli è stato ospite della trasmissione 'Contesto' su TSI 1il 27 gennaio 2009 alle ore 19:40. Ha partecipato ad un faccia a faccia sul tema del giorno "Per o Contro il World Economic Forum?" |
